National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
gemtuzumab ozogamicin (gem-TOO-zeh-mab oh-zoh-GAM-ih-sin)

 A monoclonal antibody combined with a toxic substance that is used to treat certain types of acute myeloid leukemia in older patients and is being studied in the treatment of other types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Gemtuzumab ozogamicin is a type of antibody-drug conjugate. Also called gemtuzumab and Mylotarg.

Previous Definitions:GEM 231, GEM640, gemcitabine, gemcitabine hydrochloride, gemtuzumab
Next Definitions:Gemzar, Genasense, gene, gene deletion, gene expression